If you are suffering from facial redness this study may be for you.
This study will be comparing Test Product "Oxymetazoline hydrochloride Cream, 1%" to Reference Product "RHOFADE" Cream, 1% in the Treatment of Moderate to Severe Persistent Facial Erythema of Rosacea and requires multiple visits. Each visit will be reimbursed.
Total compensation is $475.00, Visit 1 (Screening) $50.00, Visit 2 $200.00, Visit 3 (Phone call) $25.00,
Visit 4 $200.00.
For more information and to register: https://www.researchandme.com/study/160-rosacea-clinical-research-study-evanston-premier-healthcare-research